15-gene expression profile and PRAME as integrated prognostic test for uveal melanoma: First report of Collaborative Ocular Oncology Group Study No. 2 (COOG2.1)

Authors

J William Harbour, University of Texas Southwestern Medical Center
Kisha D Piggott, Washington University School of Medicine in St. Louis
et al.

Journal

Journal of Clinical Oncology

Publication Date

10-1-2024

Volume

42

Issue

28

First Page

3319

Last Page

3329

Document Type

Open Access Publication

DOI

10.1200/JCO.24.00447

Rights and Permissions

Harbour JW, Correa ZM, Schefler AC, Mruthyunjaya P, Materin MA, Aaberg TA Jr, Skalet AH, Reichstein DA, Weis E, Kim IK, Fuller TS, Demirci H, Piggott KD, Williams BK, Shildkrot E, Capone A Jr, Oliver SC, Walter SD, Mason J 3rd, Char DH, Altaweel M, Wells JR, Duker JS, Hovland PG, Gombos DS, Tsai T, Javid C, Marr BP, Gao A, Decatur CL, Dollar JJ, Kurtenbach S, Zhang S. 15-Gene Expression Profile and PRAME as Integrated Prognostic Test for Uveal Melanoma: First Report of Collaborative Ocular Oncology Group Study No. 2 (COOG2.1). J Clin Oncol. 2024 Oct;42(28):3319-3329. doi: 10.1200/JCO.24.00447. © 2024 by American Society of Clinical Oncology. Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: https://creativecommons.org/licenses/by-nc-nd/4.0/

Recommended Citation

Harbour, J William; Piggott, Kisha D; and et al., "15-gene expression profile and PRAME as integrated prognostic test for uveal melanoma: First report of Collaborative Ocular Oncology Group Study No. 2 (COOG2.1)." Journal of Clinical Oncology. 42, 28. 3319 - 3329. (2024).
https://digitalcommons.wustl.edu/oa_4/4407